BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22265744)

  • 1. Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
    Kucerova L; Poturnajova M; Tyciakova S; Matuskova M
    Stem Cell Res; 2012 Mar; 8(2):247-58. PubMed ID: 22265744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
    Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
    NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
    J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
    Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
    J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclasts direct bystander killing of cancer cells in vitro.
    Ramnaraine M; Pan W; Clohisy DR
    Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
    Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
    Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
    Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
    Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
    Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
    O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
    Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
    Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
    Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.